|Systematic (IUPAC) name|
|ATCvet code||QA04AD90 (WHO)|
|Molar mass||468.67 g/mol[[Script error: No such module "String".]]|
Maropitant (Cerenia (US)), used as maropitant citrate (USAN), is a neurokinin (NK1) receptor antagonist, which was developed by Pfizer Animal Health specifically for the treatment of motion sickness and vomiting in dogs. It has not been approved by the FDA for use in any animal except dogs. It was approved for use on February 2007.
|40x30px||This veterinary medicine–related article is a stub. You can help ssf by expanding it.|
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />